Atlas Trials

The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT04917770 · UNKNOWN

Trial details

NCT number
NCT04917770
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2021-06-30
Primary completion
2022-06-30
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.